Recruiting PHASE1 Interventional 2-arm
NCT03894163
A Phase I Study of Etrasimod in Healthy Chinese Audlt Subjects.
A Randomized, Double-Blind, Placebo-Controlled Dose-Escalation Phase I Study in Healthy Chinese Adult Subjects to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Characteristics of Etrasimod Following Oral Single and Multiple Doses Administration
Sponsor: Everstar Therapeutics Limited
Conditions
Healthy Volunteers
Interventions
Etrasimod Etrasimod Placebo
Updated 1 time since 2019 Last updated: Mar 27, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE1 clinical study on Healthy Volunteers, this trial is actively recruiting participants. The trial is conducted by Everstar Therapeutics Limited and has accumulated 1 data snapshot since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Recruiting — PHASE1
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Everstar Therapeutics Limited
Data source: Everstar Therapeutics Limited
For direct contact, visit the study record on ClinicalTrials.gov .